AngioDynamics Shares Slip After Canaccord Lowers Target On Apr 2, 2026 Canaccord cut AngioDynamics' price target after management lowered 2026 EBITDA guidance, per Investing.com; investors must now reprice near-term profitability risks.

AngioDynamics Shares Slip After Canaccord Lowers Target: On Apr 2, 2026 Canaccord cut AngioDynamics' price target after management lowered 2026 EBITDA guidance, per Investing.com; investors must now reprice near-term… 👈 Read full analysis #AngioDynamics #Investing #FinanceNews #StockMarket #EBITDA

AngioDynamics Q1 Revenue $78.42M, Non-GAAP EPS -$0.07 AngioDynamics reported Q1 2026 non-GAAP EPS of -$0.07 and revenue of $78.42M on Apr 2, 2026, beating EPS by $0.04 and revenue by $1.65M.

AngioDynamics Q1 Revenue $78.42M, Non-GAAP EPS -$0.07: AngioDynamics reported Q1 2026 non-GAAP EPS of -$0.07 and revenue of $78.42M on Apr 2, 2026, beating EPS by $0.04 and revenue by $1.65M. 👈 Read full analysis #AngioDynamics #RevenueGrowth #Q1Results #FinancialReport #Investing